Virtual Session

Ask the Experts: Preparing for the Health Equity Index
Trusted by
Arizona
Centene
Davita
desert
Health Alliance
Engagewell
Gold coast

Build a future-proof HEI strategy

The Health Equity Index (HEI) is a new framework that healthcare payers and providers must prioritize to improve Star Ratings and quality bonuses. Despite the HEI not going into effect until 2027, plans need to be prepared starting this year. Prioritizing HEI strategies will be crucial for health plans to remain financially viable and competitive in the evolving value-based care landscape.

Virtual Session

During this 40 minute virtual session, we will cover:

Star Ratings

The latest regarding the Health Equity Index determinations for SY 2027

Actions to overcome

Best practices around collecting and analyzing HEI data

D-SNP plans

Tactical approaches to navigating the complexities of members with social risk factors

Sign up now
Nate Lucena
Nate Lucena
Chief Strategy & Analytics Officer at Rex Wallace Consulting
rex wallace - new
About the Speaker

As the Chief Strategy Officer (CSO) at Rex Wallace Consulting, LLC, Nate creates and executes data-driven strategies that improve healthcare quality, health equity, and business development outcomes for clients across the managed care landscape. He has diverse experience in analytics, strategy and operations from positions in a Fortune 25 enterprise, nonprofit organizations and major research institutions.

Coby Kramer- Golinkoff
Coby Kramer-Golinkoff
Director of Customer Success
5fea2fd451956b757030534f_Group 299 1-1

As Director of Customer Success at Wellth, Coby oversees the implementation and optimization of customer programs, ensuring smooth onboarding, effective account management, and excellent outcomes for partners. Prior to Wellth, Coby led the digital health vertical at Sachs Policy Group, consulting on health policy and market entry strategy for early-stage health tech companies. He is a co-founder of Emily's Entourage, a 501(c)(3) that funds high-impact research and drug development for nonsense mutations of cystic fibrosis.